Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - magnesium sulphate - solution for injection - 50%

Bangladesh - English - DGDA (Directorate General of Drug Administration)

edcl (dhaka) - magnesium sulphate - injection - 2.5 gm/5 ml

Uganda - English - National Drug Authority

laborex uganda limited; laborex uganda limited - magnesium sulphate - parenteral ordinary ampoules - 50%w/v

Kenya - English - Pharmacy and Poisons Board

aurum pharmaceuticals ltd bampton road harold hill romford essex rm3 8ug - magnesium sulphate heptahydrate - injection - 5g/10 ml - peritoneal dialytics: electrolyte solutions

Zimbabwe - English - Medicines Control Authority

macarthys laboratories t/a martindale pharma limited - magnesium sulphate - solution; injection - 50%w/v

Zimbabwe - English - Medicines Control Authority

macarthys laboratories t/a martindale pharma limited - magnesium sulphate - solution; injection - 50%w/v

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

aurum pharmaceuticals ltd., united kingdom - magnesium sulphate - solution for injection - 50

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - magnesium sulfate heptahydrate, quantity: 500 mg/ml - injection, concentrated - excipient ingredients: water for injections - parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). for emegency treatment of some arrhythmias such as torsade de pointes and those associated with hypokalemia.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.